Latest filingSep 24, 2026Most recent Form 4
RPRX
Royalty Pharma plc
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/24 to 09/24. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$5.85M2 sells
Net open-market-$5.85M1 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly purchases, sales and code-A awards Buys Sells Awards / grants (A)
Code A includes awards, grants and other acquisitions; these are not open-market buys.
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (1)Aug 2026Sep 2026
Top insiders
By absolute net value across the selected period- HC-$5.9M
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period2transactionstxns
- S · Open-market sells · dominant2 · 100%
Activity by reported role
A joint filing can contribute to multiple roles4transactionstxns
- CHAIR · dominant2 · 50%
- EVP2 · 50%
Reported Holdings After
Separated by insider, security, and ownership type
Hite ChristopherClass A Ordinary Shares · Indirect · By SCH Investment Partners LLC
274,328Sep 22, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 24 → Sep 24
LessMore
Filing-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
RPRX transaction history
Filters apply within this company and selected period by defaultLatest insider transactions
Form 4 filings from last month. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #228928 | RPRX | Hite Christopher | EVPCHAIR | sale10b5-1 | 3.92k | -$23.1M | S | 09/24 | 09/22 |
| #228927 | RPRX | Hite Christopher | EVPCHAIR | sale10b5-1 | 96.0k | -$562M | S | 09/24 | 09/22 |
Royalty Pharma plc Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Royalty Pharma plc?
Hite Christopher.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Hite Christopher reported a sale on Sep 22, 2026 valued at $231k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $5,853,095.17. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.